NIB set to delay premiums increases until September

NEWCASTLE: Health insurer Nib is the latest fund to confirm it will push ... read more

Telix banks cash for next steps in research programme

MELBOURNE: Cancer imaging biotech Telix Pharmaceuticals has emerged from its trading halt to ... read more

Valve maker Anteris sees heartening results from trial

BRISBANE: Shares in Brisbane biotech Anteris have been swinging back and forth today ... read more

EBOS seeks clearance to acquire New Zealand LifeHealthcare

WELLINGTON: The Commerce Commission has received a clearance application in relation to the ... read more